Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease

OBJECTIVE: Although β-blockers are an established therapy in heart failure (HF) guidelines, including for patients with chronic obstructive pulmonary disease (COPD), there remain concerns regarding bronchoconstriction even with cardioselective β-blockers. We wished to assess the real-life use of β-b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipworth, Brian, Skinner, Derek, Devereux, Graham, Thomas, Victoria, Ling Zhi Jie, Joanna, Martin, Jessica, Carter, Victoria, Price, David B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136686/
https://www.ncbi.nlm.nih.gov/pubmed/27380949
http://dx.doi.org/10.1136/heartjnl-2016-309458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5136686/
https://www.ncbi.nlm.nih.gov/pubmed/27380949
http://dx.doi.org/10.1136/heartjnl-2016-309458

Ejemplares similares